NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a ...

The litigation is focused on the propriety of Zynex's statements about its sales and billing practices, its revenue recognition practices, and its relationship with the military health program for ...

Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to ...

Fintel reports that on March 12, 2025, RBC Capital downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Outperform to ...

Why: Rosen Law Firm, a global investor rights law firm, announces that an investor filed a class action on behalf of persons or entities who purchased or otherwise acquired Zynex, Inc. securities ...

On June 4, 2024, medical journal STAT published a report on Zynex entitled “How a device maker inundated pain patients with unwanted batteries and surprise bills.” The report claimed Zynex ...

Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) securities between March 13 ...

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI) securities between ...

Despite a net loss and TRICARE payment suspension, Zynex Inc (ZYXI) shows resilience with revenue growth and strategic ...

Zynex specializes in non-invasive pain management and patient monitoring, with promising advancements. Read why I think ZYXI ...

Zynex Inc. (ZYXI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.04 per share a year ago. These figures are ...